Mr. Pratap Sandhu reports

THE PRECISION PEPTIDE COMPANY INC. ANNOUNCES EXTENSION OF INVESTOR RELATIONS AGREEMENT WITH EMERGING MARKETS CONSULTING, LLC

Further to The Precision Peptide Company Inc.'s news release dated Oct. 15, 2025, it has extended its existing agreement with Emerging Markets Consulting LLC (EMC) for the continued provision of investor relations and communication services by EMC for an additional six-month term.

Emerging Markets Consulting

Based in Orlando, Fla., EMC brings multiple decades of combined experience in the investor relations industry. EMC is an international investor relations firm with affiliates around the world. EMC is relationship driven and results oriented with the goal of seeking attractive emerging companies and concentrating on its resources and efforts to serve a limited number of high-quality clients.

The extension of the engagement of EMC is for an additional six-month term commencing June 8, 2026, in consideration for a fee of $150,000 (U.S.). No company stock options were issued or will be issued to EMC. EMC's promotional activities will continue to include design, development and dissemination services for the company. EMC and its principals are arm's length from the company.

About The Precision Peptide Company Inc.

The Precision Peptide Company is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved United States facility and distributed across North America.

We seek Safe Harbor.